---
title: "COLUMN GROUP L P — Ownership Dossier"
canonical: https://whiteintel.dev/entity/4dd95970-649f-5203-bdff-cdc02e1633fb
json: https://whiteintel.dev/api/public/dossier/4dd95970-649f-5203-bdff-cdc02e1633fb
identifier: sec:0001347769
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# COLUMN GROUP L P

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001347769`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/4dd95970-649f-5203-bdff-cdc02e1633fb  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/4dd95970-649f-5203-bdff-cdc02e1633fb  

## Ownership & control

### Holdings / subsidiaries

- **NGM BIOPHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/9e4a33aa-ee21-5026-9e89-abadff47e68b
- **NGM BIOPHARMACEUTICALS INC** (tenpercentowner) — https://whiteintel.dev/entity/9e4a33aa-ee21-5026-9e89-abadff47e68b
- **Nurix Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/b60a7183-c5e9-5acd-afd8-e71eb061db09
- **CONSTELLATION PHARMACEUTICALS INC** (tenpercentowner) — https://whiteintel.dev/entity/3e050f89-697d-556a-8ad6-0eed0970e7b0
- **IMMUNE DESIGN CORP.** (tenpercentowner) — https://whiteintel.dev/entity/90dcaf96-fc16-5591-8d81-164c9a7e0cff

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **COLUMN GROUP L P**. Human view: https://whiteintel.dev/entity/4dd95970-649f-5203-bdff-cdc02e1633fb · Structured JSON: https://whiteintel.dev/api/public/dossier/4dd95970-649f-5203-bdff-cdc02e1633fb._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._